No abstract
Int J Cardiol. 2025 Jun 10;437:133499. doi: 10.1016/j.ijcard.2025.133499. Online ahead of print.
NO ABSTRACT
PMID:40505975 | DOI:10.1016/j.ijcard.2025.133499
The efficacy and safety of dapagliflozin in pediatric heart failure: Interpreting causality in clinical outcomes
Scritto il 12/06/2025
da Kaiyuan Cen